All Stories

  1. Racial Disparities in Non-Stigmatized Supportive Care Medication Use in Pancreatic Cancer

    Article • Journal of Pain and Symptom Management, March 2026, Elsevier

    Dr John M Allen

  2. Association of Glucagon‐Like Peptide‐1 Receptor Agonists With Cancer Risk in Older Adults With Type 2 Diabetes

    Article • Obesity, August 2025, Wiley

    Dr John M Allen

  3. GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity

    Article • JAMA Oncology, August 2025, American Medical Association (AMA)

    Dr John M Allen

  4. Tiered Training and Licensure for the Future of the Pharmacy Profession: Panacea or Pandora's Box?

    Article • American Journal of Pharmaceutical Education, August 2025, Elsevier

    Dr John M Allen

  5. Data from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr John M Allen

  6. Supplemental Figure S1 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr John M Allen

  7. Supplemental Table S1 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr John M Allen

  8. Table 1 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr John M Allen

  9. Table 2 from Racial Disparities in Analgesic and Psychiatric Medication Use During End-Of-Life Care in Advanced-Stage Colorectal Cancer: A Retrospective Cohort Study

    Article • July 2025, American Association for Cancer Research (AACR)

    Dr John M Allen

  10. A fair machine learning model to predict flares of systemic lupus erythematosus

    Article • JAMIA Open, July 2025, Oxford University Press (OUP)

    Dr John M Allen

  11. Training the Next Generation of Researchers to Advance Cancer Health Equity: Five Years of Experience from the Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center

    Article • Journal of Cancer Education, June 2025, Springer Science + Business Media

    Dr John M Allen

  12. Racial disparities in analgesic and psychiatric medication use during end-of-life care in advanced-stage colorectal cancer: A Retrospective Cohort Study

    Article • Cancer Research Communications, June 2025, American Association for Cancer Research (AACR)

    Dr John M Allen

  13. Implementation and evaluation of a stop the bleed program at a college of pharmacy

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, April 2025, Wiley

    Dr John M Allen

  14. Regional trends and disparities in newer GLP1 receptor agonist initiation among real‐world adult patients eligible for obesity treatment

    Article • Diabetes Obesity and Metabolism, March 2025, Wiley

    Dr John M Allen

  15. Structural factors and their influence on the use of novel antidiabetic agents: Making the case for increased awareness and access to clinical pharmacy services

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, November 2024, Wiley

    Dr John M Allen

  16. A change to the pathway: The Impact of the Supreme Court of the United States affirmative action decision on clinical pharmacy and a call to action for pharmacists

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, June 2024, Wiley

    Dr John M Allen

  17. Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes

    Article • PLOS One, January 2024, PLOS

    Dr John M Allen

  18. Data from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  19. Data from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  20. Supplemental Table 1 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  21. Supplemental Table 1 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  22. Supplemental Table 2 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  23. Supplemental Table 2 from Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

    Article • December 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  24. Clinical pharmacists addressing social determinants of health needs and eliminating health disparities: Bystander or change agent?

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, December 2023, Wiley

    Dr John M Allen

  25. Unraveling Racial Disparities in Supportive Care Medication Use among End-of-Life Pancreatic Cancer Patients: Focus on Pain Management and Psychiatric Therapies

    Article • Cancer Epidemiology Biomarkers & Prevention, October 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  26. Community Champions: The Crucial Contribution of an Independent Pharmacy in COVID-19 Vaccination Efforts in an Underserved Community

    Article • International Journal of Environmental Research and Public Health, October 2023, MDPI AG

    Dr John M Allen

  27. Implementing innovative teaching strategies to promote student academic engagement in a critical care elective

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, June 2023, Wiley

    Dr John M Allen

  28. Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans

    Article • Journal of the National Medical Association, April 2023, Elsevier

    Dr John M Allen

  29. Curricular changes in times of crisis: Lessons learned

    Article • Currents in Pharmacy Teaching and Learning, January 2023, Elsevier

    Dr John M Allen

  30. Abstract A026: Disparities in the use of pain medication in patients with pancreatic cancer: Focus on racial and ethnic minorities

    Article • Cancer Epidemiology Biomarkers & Prevention, January 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  31. Abstract A027: Evaluation of psychotropic medication usage patterns in patients with pancreatic cancer by race/ethnicity

    Article • Cancer Epidemiology Biomarkers & Prevention, January 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  32. Abstract C026: Pharmacogenetics of pancreatic ductal adenocarcinoma: A review of racial disparities

    Article • Cancer Epidemiology Biomarkers & Prevention, January 2023, American Association for Cancer Research (AACR)

    Dr John M Allen

  33. Evaluation of Potential Racial Disparities inCYP2C19‐Guided P2Y12Inhibitor Prescribing After Percutaneous Coronary Intervention

    Article • Clinical Pharmacology & Therapeutics, November 2022, Wiley

    Dr John M Allen

  34. A scoping review on the relationship between race/ethnicity and the receipt of supportive care medications during cancer treatment: Implications for the clinical pharmacist

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, November 2022, Wiley

    Dr John M Allen

  35. Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study

    Article • Annals of Pharmacotherapy, September 2022, SAGE Publications

    Dr John M Allen

  36. Pharmacoequity and the clinical pharmacist: Why not us, why not now!

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, August 2022, Wiley

    Dr John M Allen

  37. Cognitive Testing of PAINReportIt-Spanish in Monolingual Hispanic Adults

    Article • Cancer Nursing, May 2022, Wolters Kluwer Health

    Dr John M Allen

  38. Pharmacy student self-assessment of strength of residency candidacy compared to clinical faculty

    Article • Currents in Pharmacy Teaching and Learning, March 2022, Elsevier

    Dr John M Allen

  39. Abstract PO-270: Evaluation of attitudes, beliefs and influences and their impact on HPV vaccination rates among minority health science students

    Article • Cancer Epidemiology Biomarkers & Prevention, January 2022, American Association for Cancer Research (AACR)

    Dr John M Allen

  40. Pharmacokinetics in patients requiring renal replacement therapy

    Article • January 2022, Elsevier

    Dr John M Allen

  41. Abstract PO-056: The ReTOOL training program for underrepresented minority students: Best practices for virtual training in midst of COVID-19

    Article • Cancer Epidemiology Biomarkers & Prevention, January 2022, American Association for Cancer Research (AACR)

    Dr John M Allen

  42. 1435: EVALUATION OF BLACK-WHITE RACIAL DISPARITIES IN SEPSIS PATIENTS TREATED WITH PIPERACILLIN-TAZOBACTAM

    Article • Critical Care Medicine, December 2021, Wolters Kluwer Health

    Dr John M Allen

  43. Addressing challenges of providing remote inpatient clinical pharmacy services

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, November 2021, Wiley

    Dr John M Allen

  44. Ten recommendations to increase Black representation within pharmacy organization leadership

    Article • American Journal of Health-System Pharmacy, March 2021, Oxford University Press (OUP)

    Dr John M Allen

  45. Impact of supplemental individual verbal defense on confidence, engagement, and performance in a team-based learning therapeutics course

    Article • Currents in Pharmacy Teaching and Learning, February 2021, Elsevier

    Dr John M Allen

  46. 853: Comparison of Common Piperacillin-Tazobactam Dosing Strategies in Patients With Septic Shock

    Article • Critical Care Medicine, December 2020, Wolters Kluwer Health

    Dr John M Allen

  47. 892: Impact of a Multimedia Approach to Rapid Response Team Training in a Pharmacy Critical Care Elective

    Article • Critical Care Medicine, December 2020, Wolters Kluwer Health

    Dr John M Allen

  48. COVID-19 Therapeutics: Making Sense of It All

    Article • AACN Advanced Critical Care, September 2020, AACN Publishing

    Dr John M Allen

  49. Abstract D057: Impact of antibiotic exposure on the overall survival in patients receiving immune checkpoint inhibitors: Does race matter?

    Article • Cancer Epidemiology Biomarkers & Prevention, June 2020, American Association for Cancer Research (AACR)

    Dr John M Allen

  50. 1382

    Article • Critical Care Medicine, January 2020, Wolters Kluwer Health

    Dr John M Allen

  51. 960

    Article • Critical Care Medicine, January 2020, Wolters Kluwer Health

    Dr John M Allen

  52. Angiotensin II: A New Vasopressor for the Treatment of Distributive Shock

    Article • Clinical Therapeutics, October 2019, Elsevier

    Dr John M Allen

  53. Cefazolin Versus Anti-Staphylococcal Penicillins for the Treatment of Patients with Methicillin-Susceptible Staphylococcus aureus Infection: A Meta-Analysis with Trial Sequential Analysis

    Article • Infectious Diseases and Therapy, August 2019, Springer Science + Business Media

    Dr John M Allen

  54. Effect of prescriber peer comparison reports on fluoroquinolone use across a 16-facility community hospital system

    Article • JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, April 2019, Wiley

    Dr John M Allen

  55. Recent Updates in the Pharmacological Management of Sepsis and Septic Shock: A Systematic Review Focused on Fluid Resuscitation, Vasopressors, and Corticosteroids

    Article • Annals of Pharmacotherapy, November 2018, SAGE Publications

    Dr John M Allen

  56. 667

    Article • Critical Care Medicine, January 2018, Wolters Kluwer Health

    Dr John M Allen

  57. Major publications in the critical care pharmacotherapy literature: January-December 2013

    Article • American Journal of Health-System Pharmacy, January 2015, American Society of Health System Pharmacists

    Dr John M Allen

  58. Vasoactive Substances and Nutrition in Critical Care

    Article • January 2015, Springer Science + Business Media

    Dr John M Allen

  59. Vasoactive Substances and Nutrition in Critical Care

    Article • January 2014, Springer Science + Business Media

    Dr John M Allen

  60. Understanding Vasoactive Medications

    Article • Journal of Infusion Nursing, January 2014, Wolters Kluwer Health

    Dr John M Allen

  61. 914

    Article • Critical Care Medicine, December 2013, Wolters Kluwer Health

    Dr John M Allen

  62. Abstracts and Index of Authors

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2013, Wiley

    Dr John M Allen, Dr. Mohamed Omar Saad

  63. Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population

    Article • The American Journal of Surgery, March 2013, Elsevier

    Dr John M Allen

  64. Ventriculoperitoneal Shunt Infections in Adult Patients

    Article • AACN Advanced Critical Care, January 2013, AACN Publishing

    Dr John M Allen

  65. Interpreting Laboratory Data

    Article • Critical Care Medicine, October 2012, Wolters Kluwer Health

    Dr John M Allen

  66. Abstracts and Index of Authors

    Article • Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, October 2012, Wiley

    Dr John M Allen

  67. Vasoactive Substances and Their Effects on Nutrition in the Critically Ill Patient

    Article • Nutrition in Clinical Practice, April 2012, SAGE Publications

    Dr John M Allen

  68. Prevention, Recognition, and Management of Delirium in the Intensive Care Unit

    Article • AACN Advanced Critical Care, January 2012, AACN Publishing

    Dr John M Allen

  69. Evaluation of Recombinant Factor VIIa Off-Label Use at an Acute Care Hospital With Established Guidelines for Use

    Article • Hospital Pharmacy, March 2011, Thomas Land Publishers

    Dr John M Allen